{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:21:25Z","timestamp":1781508085086,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.maturitas.2011.03.011","type":"journal-article","created":{"date-parts":[[2011,4,18]],"date-time":"2011-04-18T18:23:16Z","timestamp":1303150996000},"page":"195-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["EMAS position statement: Managing menopausal women with a personal or family history of VTE"],"prefix":"10.1016","volume":"69","author":[{"given":"Florence","family":"Tremollieres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Brincat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Tamer","family":"Erel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gambacciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Lambrinoudaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette H.","family":"Moen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Schenck-Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Vujovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Rozenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2011.03.011_bib0005","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1161\/CIRCULATIONAHA.105.565556","article-title":"Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration","volume":"112","author":"Straczek","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0010","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1055\/s-0037-1613887","article-title":"Incidence of venous thromboembolism: a community-based study in Western France, EPI-GETBP Study Group. Groupe d\u2019Etude de la Thrombose de Bretagne Occidentale","volume":"83","author":"Oger","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0015","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2007.02450.x","article-title":"Incidence and mortality of venous thrombosis: a population-based study","volume":"5","author":"Naess","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ajh.21917","article-title":"Prevalence of clinical venous thromboembolism in the USA: current trends and future projections","volume":"86","author":"Deitelzweig","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0025","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/j.1538-7836.2005.01458.x","article-title":"The first ambulatory screening on thromboembolism: a multicentre, cross-sectional, observational study on risk factors for venous thromboembolism","volume":"3","author":"Di Minno","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0030","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1538-7836.2006.01933.x","article-title":"Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration, The ESTHER Study","volume":"4","author":"Canonico","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0035","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-132-9-200005020-00002","article-title":"Postmenopausal hormone therapy increases risk for venous thromboembolic disease, The Heart and Estrogen\/progestin Replacement Study","volume":"132","author":"Grady","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0040","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1538-7836.2005.01693.x","article-title":"Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism","volume":"4","author":"Simon","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.288.1.58","article-title":"Noncardiovascular disease outcomes during 6.8years of hormone therapy: heart and Estrogen\/progestin Replacement Study follow-up (HERS II)","volume":"288","author":"Hulley","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risk and benefits of estrogen plus progestin in health postmenopausal women","volume":"288","author":"Writing Group for the Women's Health Initiative Investigators","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0055","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","article-title":"Estrogen plus progestin and risk of venous thrombosis","volume":"292","author":"Cushman","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0060","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0065","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0070","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","article-title":"Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis","volume":"336","author":"Canonico","year":"2008","journal-title":"BMJ Clin Res"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0075","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/MOH.0b013e32833c07bc","article-title":"Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women","volume":"17","author":"Oli\u00e9","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0080","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.maturitas.2010.10.005","article-title":"EMAS position statement: managing the menopause in the context of coronary hear disease","volume":"68","author":"Schenk-Gustafsson","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0085","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"For the Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators, Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized trial","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0090","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0800743","article-title":"for the LIFT Trial investigators. The effects of tibolone in older postmenopausal women","volume":"359","author":"Cummings","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0095","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk","volume":"362","author":"Scarabin","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0100","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/ATVBAHA.109.196022","article-title":"Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study","volume":"30","author":"Canonico","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0105","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/13697130902780853","article-title":"Risk of cardiovascular outcomes in users of estradiol\/dydrogesterone or other HRT preparations","volume":"12","author":"Schneider","year":"2009","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0110","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1538-7836.2010.03839.x","article-title":"Hormone replacement therapy and the risk of venous thromboembolism: population-based study","volume":"8","author":"Renoux","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0115","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2141.2010.08128.x","article-title":"Reproductive history, hormone replacement, and incidence of venous thromboembolism: the longitudinal investigation of thromboembolism etiology","volume":"149","author":"Ohira","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0120","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"for the Estrogen and Thromboembolism Risk (ESTHER) Study. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0125","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1055\/s-0037-1616085","article-title":"Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein \u2013 a cross-sectional population survey","volume":"86","author":"Lowe","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0130","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1161\/01.ATV.17.11.3071","article-title":"Effects of oral and transdermal estrogen\/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women, A randomized controlled trial","volume":"17","author":"Scarabin","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0135","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.ATV.0000087141.05044.1F","article-title":"Differential effects of oral and transdermal estrogen\/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial","volume":"23","author":"Oger","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0140","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/j.1538-7836.2010.03953.x","article-title":"The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy","volume":"8","author":"Bagot","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0145","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0150","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(99)06092-4","article-title":"Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study","volume":"354","author":"Rosing","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0155","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2141.2001.03111.x","article-title":"Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial","volume":"115","author":"Hoibraaten","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0160","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/01.ATV.0000074146.36646.C8","article-title":"Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women","volume":"23","author":"Post","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0165","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/gme.0b013e3181e102eb","article-title":"Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen","volume":"17","author":"Canonico","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0170","article-title":"Hormone therapy and other risk factors for recurrence of venous thromboembolism among postmenopausal women","author":"Olie","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0175","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.ATV.0000018301.91721.94","article-title":"Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease","volume":"22","author":"Herrington","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0180","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1046\/j.0007-1048.2002.03356.x","article-title":"Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis","volume":"116","author":"Rosendaal","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0185","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.maturitas.2010.03.025","article-title":"EMAS position statement: management of obese postmenopausal women","volume":"66","author":"Lambrinoudaki","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-007-9523-x","article-title":"Unequal risks for breast cancer associated with different hormone replacement therapies: results of the E3N cohort study","volume":"107","author":"Fournier","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0195","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/AOG.0b013e31818e8cd6","article-title":"Breast cancer risk in postmenopausal women using estradiol-progestogen therapy","volume":"113","author":"Lyytinen","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2011.03.011_bib0200","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/CIRCULATIONAHA.106.675405","article-title":"Are some types of hormone therapy safer than others?: lessons from the estrogen and thromboembolism risk study","volume":"115","author":"Rexrode","year":"2007","journal-title":"Circulation"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512211000934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512211000934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:51:35Z","timestamp":1759913495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512211000934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0378512211000934"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2011.03.011","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EMAS position statement: Managing menopausal women with a personal or family history of VTE","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2011.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}